The Digital Medicine Society (DiMe) announced today a new collaboration with Acclinate, Amgen, GSK, Lightship, Medable, Rubix LS, Sage Bionetworks, Savvy Cooperative, and THREAD Research to drive inclusion in digital clinical trials. The initiative aims to provide the tools and framework necessary to successfully integrate diverse perspectives during the planning process for trials that include a technology device for participation.
At first glance, data looks objective—numbers, percentages, trends. But behind every data point is a real person, living in a real community, navigati...
Key Takeaways and Learnings As advanced data analytics and AI take hold in healthcare, sponsors shouldn’t overlook the potential to predict who will e...
Key Takeaways and Learnings Community engagement is critical to improving health equity, but it has to start long before sponsors recruit patients for...
When we talk about disparities in healthcare, we often focus on patient access—who gets invited to participate in clinical trials or who receives care...
Innovation isn't a destination. It's a journey of continuous learning. At Acclinate, we're committed to building the future of equitable clinical rese...
I’ll never forget what someone said to us in the early days of building Acclinate: “Just don’t come here, plant your flag, and leave.”
Value-based care (VBC) continues to stand as a promising model for improving patient outcomes and controlling healthcare costs. But amidst the drive f...
